Announcements
- MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
- Notice of AGM
- Total Voting Rights
- Notice of Results
- MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024
- Total Voting Rights and Block Listing Return
- Signing of Strategic Platform License
- MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)
- Exercise of options and PDMR dealing
- Grant of Options, RSUs and PSUs and PDMR Dealing
More ▼
Key statistics
On Tuesday, MaxCyte Inc (MYE0:FRA) closed at 3.42, 47.41% above the 52 week low of 2.32 set on Oct 06, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.60 |
---|---|
High | 3.60 |
Low | 3.32 |
Bid | 3.48 |
Offer | 3.84 |
Previous close | 3.48 |
Average volume | 0.00 |
---|---|
Shares outstanding | 104.54m |
Free float | 98.05m |
P/E (TTM) | -- |
Market cap | 408.77m USD |
EPS (TTM) | -0.3675 USD |
Data delayed at least 15 minutes, as of May 07 2024 14:29 BST.
More ▼